Isodiol International Inc (ISOLF)
0.00
USD |
OTCM |
Apr 23, 16:00
Isodiol International Cash from Financing (TTM): -2.450M for Dec. 31, 2019
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2019 | -2.450M |
September 30, 2019 | 2.034M |
June 30, 2019 | 4.545M |
March 31, 2019 | 18.82M |
December 31, 2018 | 26.98M |
September 30, 2018 | 52.34M |
June 30, 2018 | 52.27M |
March 31, 2018 | 43.03M |
December 31, 2017 | 36.13M |
September 30, 2017 | 7.238M |
Date | Value |
---|---|
June 30, 2017 | 5.47M |
March 31, 2017 | 2.922M |
December 31, 2016 | 2.031M |
September 30, 2016 | 1.388M |
June 30, 2016 | 1.291M |
March 31, 2016 | 1.234M |
December 31, 2015 | 1.173M |
September 30, 2015 | 0.6736M |
June 30, 2015 | 0.5535M |
March 31, 2015 | 0.7274M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.450M
Minimum
Dec 2019
4.545M
Maximum
Jun 2019
1.376M
Average
2.034M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
Acasti Pharma Inc | 7.359M |
Aurinia Pharmaceuticals Inc | -5.13M |
Edesa Biotech Inc | 2.224M |
Lexaria Bioscience Corp | 6.862M |
Liminal Biosciences Inc (DELISTED) | -4.278M |